Conflict of Interest Statement/Disclosures:
RK consultancies: Agios Pharmaceuticals, Amgen Inc, Hoffman La Roche, Novo Nordisk, Octapharma AG, Sanofi, and Takeda. RFG: Research Funding: Agios, Dova (Sobi), Novartis; Consultancy: Agios, Principia (Sanofi)
JL consultancies: Agios Pharmaceuticals, Forma Therapeutics, Novartis, Bioproducts, Laboratory
ML consultancies: MPL is an advisory board member for Octapharma, Dova, Principia and Shionogi, a consultant for Novartis, Shionogi, Dova, Principia, Argenx, Rigel and the DOJ, and has received research funding from Sysmex, Novartis, Rigel, Principia, Argenx, Dova, Octapharma and Astra Zeneca.